[CAS NO. 877963-94-5]  LOC14

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [877963-94-5]

Catalog
HY-100432
Brand
MCE
CAS
877963-94-5

DESCRIPTION [877963-94-5]

Overview

MDLMFCD07849042
Molecular Weight317.41
Molecular FormulaC16H19N3O2S
SMILESO=C(C(C=CC=C1)=C1S2)N2CN3CCN(C(C4CC4)=O)CC3

For research use only. We do not sell to patients.

Summary

LOC14 is a potent Protein disulfide isomerase ( PDI ) inhibitor with EC 50 and K d values of 500 nM and 62 nM, respectively. LOC14 exhibits high stability in mouse liver microsomes and blood plasma, low intrinsic microsome clearance, and low plasma-protein binding [1] . LOC14 inhibits PDIA3 activity, decreases intramolecular disulfide bonds and subsequent oligomerization (maturation) of HA in lung epithelial cells [3] .


IC50 & Target

Kd: 62 nM (PDI) [1]


In Vitro

LOC14 (0.01-100 μM; 24 hours) exhibits the capacity to inhibit recombinant (r)PDIA3 at an IC50 of approximately 5 μM [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [3]

Cell Line: MTEC cells
Concentration: 0.01 μM; 0.1 μM; 0.5 μM; 1 μM; 5 μM; 10 μM; 100 μM
Incubation Time: 24 hours
Result: Inhibited recombinant (r)PDIA3 activity.

In Vivo

LOC14 (orally administered by gavage; 20 mg/kg; once daily; 12-28 weeks) significantly improves motor function, attenuated brain atrophy and extended survival in the N171–82Q HD mice [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male N171–82Q HD mice [2]
Dosage: 20 mg/kg
Administration: Orally administered by gavage; 20 mg/kg; once daily; 12-28 weeks
Result: Improved motor function in HD mice.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, protect from light

* The compound is unstable in solutions, freshly prepared is recommended.


Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL ( 157.52 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.1505 mL 15.7525 mL 31.5050 mL
5 mM 0.6301 mL 3.1505 mL 6.3010 mL
10 mM 0.3150 mL 1.5752 mL 3.1505 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (6.55 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (6.55 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (6.55 mM); Clear solution

* All of the co-solvents are available by MCE.